
Atrotas 0.6mg Injection
Marketer
Intas Pharmaceuticals Ltd
Salt Composition
Atropine (0.6mg)
Overview Atrotas 0.6mg Injection
Atropine 0.6mg Injection treats bradycardia (a slow heart rate), restoring normal heart rhythm in cardiac arrest. Administered pre-operatively, it reduces salivary secretions during general anesthesia. It also counteracts certain insecticide poisonings. This injection may be combined with other medications to counteract muscle relaxants' effects during surgery. Dosage is determined and administered by a healthcare professional. Inform your physician of all other medications you are taking, as interactions are possible. Blurred vision and tachycardia (rapid heart rate) are common side effects; dry mouth can also occur, necessitating increased fluid intake and diligent oral hygiene. Pregnant or lactating individuals should seek medical advice before use. Patients with severe heart conditions or urinary retention should generally avoid this medication.
Uses of Atrotas 0.6mg Injection
Slow heart rate
Major Benefits of Atrotas 0.6mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Atrotas 0.6mg Injection:
- Injection site pain
How to use Atrotas 0.6mg Injection:
This medication will be administered by your physician or their registered nurse; self-medication is strictly prohibited.
How Atrotas 0.6mg Injection works:
Atrotas 0.6mg Injection, an anticholinergic agent, inhibits the neurotransmitter acetylcholine. This action reduces glandular secretions (such as saliva and sweat) pre-operatively, elevates bradycardia, and mitigates intestinal spasms. Furthermore, it serves as a counteragent in specific poisonings and neutralizes the effects of some muscle relaxants.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Atrotas 0.6mg Injection and alcohol may lead to increased sleepiness.
PregnancyCONSULT YOUR DOCTOR
Administering Atrotas 0.6mg Injection during pregnancy carries a confirmed risk to the fetus. Its use is contraindicated except in rare, life-threatening circumstances where potential benefits outweigh the known hazards. Physician consultation is mandatory.
Breast feedingSAFE IF PRESCRIBED
The 0.6mg Atrotas injection presents a low risk during lactation. Research in humans indicates minimal drug transfer into breast milk, posing no discernible harm to the infant. A reduction in milk production is possible.
DrivingUNSAFE
Administering Atrotas 0.6mg Injection can lead to drowsiness, blurred vision, and dizziness, potentially impairing alertness. Driving should be avoided if these effects are experienced.
KidneyCAUTION
Exercise caution when administering Atrotas 0.6mg Injection to individuals with impaired renal function. Dosage modification for Atrotas 0.6mg Injection might be necessary. Physician consultation is recommended.
LiverCAUTION
Exercise caution when administering Atrotas 0.6mg Injection to individuals with hepatic impairment; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Atrotas 0.6mg Injection :
Should you forget a dose of Atrotas 0.6mg Injection, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Atrotas 0.6mg Injection
| Label | Value |
|---|---|
| Chemical Type | Naturally Occurring Alkaloids |
| Developing Habits | No. |
| Treatment Category | Ophthalmology |
